Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials

被引：4
作者：
de Jongh, Adriaan D. [1 ]
van den Berg, Leonard H. [1 ]
van Eijk, Ruben P. A. [1 ,2 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands
[2] Julius Ctr Hlth Sci & Primary Care, Biostat & Res Support, Utrecht, Netherlands
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2021年 / 92卷 / 05期
关键词：
ALS; randomised trials; motor neuron disease;
D O I：
10.1136/jnnp-2020-325253
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：569 / 570
页数：2
相关论文
共 50 条
  • [31] A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis
    Beswick, Emily
    Park, Emily
    Wong, Charis
    Mehta, Arpan R.
    Dakin, Rachel
    Chandran, Siddharthan
    Newton, Judith
    Carson, Alan
    Abrahams, Sharon
    Pal, Suvankar
    JOURNAL OF NEUROLOGY, 2021, 268 (12) : 4510 - 4521
  • [32] How can we improve clinical trials in amyotrophic lateral sclerosis?
    Gordon, Paul H.
    Meininger, Vincent
    NATURE REVIEWS NEUROLOGY, 2011, 7 (11) : 650 - 654
  • [33] Methodological Quality of Clinical Trials in Amyotrophic Lateral Sclerosis: A Systematic Review
    Pupillo, Elisabetta
    Al-Chalabi, Ammar
    Sassi, Serena
    Arippol, Emilio
    Tinti, Lorenzo
    Vitelli, Eugenio
    Copetti, Massimiliano
    Leone, Maurizio A.
    Bianchi, Elisa
    JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (04) : 749 - 765
  • [34] A PLACEBO ARM IS NOT ALWAYS NECESSARY IN CLINICAL TRIALS OF AMYOTROPHIC LATERAL SCLEROSIS
    Gordon, Paul H.
    MUSCLE & NERVE, 2009, 39 (06) : 858 - 860
  • [35] Innovating Clinical Trials for Amyotrophic Lateral Sclerosis Challenging the Established Order
    van Eijk, Ruben P. A.
    Nikolakopoulos, Stavros
    Roes, Kit C. B.
    Kendall, Lindsay
    Han, Steve S.
    Lavrov, Arseniy
    Epstein, Noam
    Kliest, Tessa
    de Jongh, Adriaan D.
    Westeneng, Henk-Jan
    Al-Chalabi, Ammar
    Van Damme, Philip
    Hardiman, Orla
    Shaw, Pamela J.
    McDermott, Christopher J.
    Eijkemans, Marinus J. C.
    van den Berg, Leonard H.
    NEUROLOGY, 2021, 97 (11) : 528 - 536
  • [36] Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
    Khalid, Syed I.
    Ampie, Leonel
    Kelly, Ryan
    Ladha, Shafeeq S.
    Dardis, Christopher
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [37] The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
    Redler, Rachel L.
    Dokholyan, Nikolay V.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 215 - 262
  • [38] Overview of Lipid Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
    Trostchansky, Andres
    ROLE OF BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES, 2019, 1161 : 233 - 241
  • [39] Home care of patients with amyotrophic lateral sclerosis (ALS)
    Krivickas, LS
    Shockley, L
    Mitsumoto, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 152 : S82 - S89
  • [40] White matter injury in amyotrophic lateral sclerosis (ALS)
    Rafalowska, J
    Dziewulska, D
    FOLIA NEUROPATHOLOGICA, 1996, 34 (02): : 87 - 91
12345